Pure Global AI
NCT06237595Recruiting

Vagus Nerve Stimulation in Fibromyalgia

Comparative Study Between the Outcome of Noninvasive Vagus Nerve Stimulation and Medical Treatment in Fibromyalgia Patients
Kasr El Aini HospitalClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Fibromyalgia
Drug/Device/Intervention
Vagus nerve stimulation
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Kasr El Aini Hospital
Location
Cairo, Egypt
Timeline & enrollment
Phase
N/A
Start date
Sep 30, 2023
End date
Feb 28, 2025
Enrollment
90 participants
Primary outcome

Visual analogue scale 0-10,Symptom severity scale score,Widespread pain index,Fibromyalgia severity scale

Summary

Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve
 sympathetic hyperactivity in fibromyalgia patients. We aimed in the current study, to
 evaluate the effect of the cervical transcutaneous vagus nerve stimulation in comparison to
 conventional medical treatment in Egyptian fibromyalgia patients.

ICD-10 classifications
FibromyalgiaMyalgiaFibrothoraxCervicalgiaEpidemic myalgia
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06237595
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06237595 through Pure Global AI's free database. This phase not specified trial is sponsored by Kasr El Aini Hospital and is currently Recruiting. The study focuses on Fibromyalgia. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.